ArticleBlood neoplasia2025

Targeting CDK9 inhibits the growth of KMT2A-rearranged infant leukemia and demonstrates synergy with menin inhibition.

Ritul Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.